Literature DB >> 18831942

Blood cholesterol concentration measured by CR3000: fingerstick versus venous sampling.

V Sblendorio, B Palmieri, G Riccioni.   

Abstract

Currently, the clinical practice of desktop or Point of Care (PoC) analyzers for lipid measurements has gained wide popularity. Designed to quickly perform measurements on microlitre(microL) quantities of blood, these instruments can be used in non-laboratory settings, such as physicians offices or field-testing sites and can provide measurements in whole blood, serum, or plasma, using either venous or capillary blood samples. The aim of this study is to examine the relationship between cholesterol determinations in venous and capillary samples using the CR3000 PoC system. The study was performed on 21 unselected adult volunteers, and no exclusion criteria was adopted. The mean cholesterol concentration for the venous blood samples measured was 164 mg/dL. The values obtained in the capillary blood samples averaged 168 mg/dL, which is only slightly higher (e.g., 2.87%) than the venous sample measurements. Moreover, the total variance was statistically similar for venous and capillary measurements (F value = 1.199, where the upper critical value of the F distribution is 2.124, p < 0.05). The results of our study support the concept that CR3000 total cholesterol testing can be performed safely and accurately in either venous or capillary specimens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18831942     DOI: 10.1177/039463200802100328

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  2 in total

1.  Free-Living Humans Cross Cardiovascular Disease Risk Categories Due to Daily Rhythms in Cholesterol and Triglycerides.

Authors:  Azure D Grant; Gary I Wolf
Journal:  J Circadian Rhythms       Date:  2019-04-24

2.  Whole genome transcript profiling from fingerstick blood samples: a comparison and feasibility study.

Authors:  Elizabeth H Robison; Tony S Mondala; Adam R Williams; Steven R Head; Daniel R Salomon; Sunil M Kurian
Journal:  BMC Genomics       Date:  2009-12-17       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.